Task: Answer the MCQ question.
Question: Which drug exhibits a 9.063% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. Cc1ccc(C)c(C(=O)COc2ccccc2[N+](=O)[O-])c1
b. COc1cc(OC)cc(C(=O)Nc2ccccc2C(=O)NC2CC2)c1
Answer: b. COc1cc(OC)cc(C(=O)Nc2ccccc2C(=O)NC2CC2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cc(OC)cc(C(=O)Nc2ccccc2C(=O)NC2CC2)c1
COc1cc(OC)cc(C(=O)Nc2ccccc2C(=O)NC2CC2)c1
N-[2-(cyclopropylcarbamoyl)phenyl]-3,5-dimethoxybenzamide